Lynn Madden, PhD, MPA
Assistant Professor AdjunctCards
Appointments
Additional Titles
President/CEO, Administration, APT Foundation, Inc.
Contact Info
Appointments
Additional Titles
President/CEO, Administration, APT Foundation, Inc.
Contact Info
Appointments
Additional Titles
President/CEO, Administration, APT Foundation, Inc.
Contact Info
About
Titles
Assistant Professor Adjunct
Positions outside Yale
President/CEO, Administration, APT Foundation, Inc.
Biography
Since 2006, I have served as Chief Executive Officer of the APT Foundation, a non-profit agency founded in 1970 by members of the Yale University Department of Psychiatry to promote health and recovery for those who live with substance use disorders and/or mental illness. My professional interests focus on identifying treatment gaps in substance abuse/mental health treatment and improving access to those services including services for persons who are incarcerated or recently released from jail or prison.
My academic interests and pursuits include large- and small-scale implementation projects that are focused on access to and quality in mental health care and substance abuse treatment services including integration with primary care, and integration of treatment for infectious diseases such as HIV/AIDS and HCV. My role in these project teams is often as both coach and researcher. I currently hold a position as an assistant professor in the Yale School of Medicine AIDS program and as a faculty member in addiction medicine.
Appointments
Infectious Diseases
Assistant Professor AdjunctPrimary
Other Departments & Organizations
- Addiction Medicine Fellowship Program
- Infectious Diseases
- Internal Medicine
- J. Meyer Lab
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative
Education & Training
- PhD
- Union Institute & University, Interdisciplinary Studies/Public Policy and Social Change (2017)
- MPA
- University of Maine (1997)
- BA
- University of Maine (1995)
Research
Overview
Since 2004, the focus of my work has been the relationship between improved access to care, particularly mental health, substance abuse and infectious diseases treatment, and the resultant improvements in both patient outcomes and financial performance. I have contributed to the refinement and theoretical understanding of the rapid cycle process improvement model as advanced by NIATX (www.NIATx.net) headquartered at the University of Wisconsin-Madison. I have used this model as both a coach and a researcher in working with individual organizations, state level learning collaboratives, and learning collaboratives composed of organizations throughout the US and in Ukraine. Specific contributions to science cluster in three areas: Improving Access to and Retention in Substance Abuse Treatment, Enhancing Integration Between Substance Abuse Treatment Services and Infectious Diseases, and
Developing Strategies for Systems and Clinicians to Respond Effectively to Complex Patients.
Research at a Glance
Yale Co-Authors
Publications Timeline
Frederick Lewis Altice, MD, MA
Declan Barry, PhD
Mark Beitel, PhD
Jeanette Tetrault, MD, FACP, FASAM
Alexei Zelenev, PhD
Carolina E Price, MPA
Publications
2024
Transformation of the HIV treatment cascade for people who inject drugs in Ukraine.
Bromberg D, Rhoades D, Madden L, Ivasiy R, Meteliuk A, Pyaklo I, Filippovych M, Nikitin B, Farnum S, Fomenko T, Dvoriak S, Altice F. Transformation of the HIV treatment cascade for people who inject drugs in Ukraine. AIDS 2024 PMID: 39589135, DOI: 10.1097/qad.0000000000004056.Peer-Reviewed Original ResearchCitationsConceptsOpioid agonist therapyAntiretroviral therapyImprove HIV treatment outcomesHIV treatment outcomesHIV care cascadeCross-sectional biobehavioral surveyTreatment outcomesCare cascadeUkraine's HIV epidemicPrescription of antiretroviral therapyPrescribed antiretroviral therapyAdherence to antiretroviral therapyHIV treatment cascadeAgonist therapyBiobehavioral surveyOpioid dependenceHIV diagnosisTreatment cascadeHIV epidemicHIVOpioidPWIDTherapyDrugOutcomesStrategies to Deimplement Opioid Prescribing in Primary Care
Quanbeck A, Robinson J, Jacobson N, Li X, Hennessy-Garza R, Landeck J, Cohen A, Madden L, Pulvermacher A, Brown R. Strategies to Deimplement Opioid Prescribing in Primary Care. JAMA Network Open 2024, 7: e2438325. PMID: 39388183, PMCID: PMC11581553, DOI: 10.1001/jamanetworkopen.2024.38325.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCluster randomized clinical trialDeimplementation strategiesMorphine milligram equivalent doseMorphine milligram equivalentsPractice facilitationOpioid prescribingIncreased screeningTreatment agreementsUS health care systemCenters for Disease Control and Prevention guidelinesRandomized clinical trialsUrine drug screensPrimary care clinicsPrimary care settingPrimary outcomeMental health screeningPain-related interferenceHealth care systemHigh-intensity groupEnjoyment of lifeChronic pain managementPrimary careCare clinicsCare settingsHealth screeningClinical characteristics associated with problematic pornography use among individuals seeking treatment for opioid use disorder.
Stefanovics E, Kraus S, Madden L, Farnum S, Cannata E, Potenza M, Barry D. Clinical characteristics associated with problematic pornography use among individuals seeking treatment for opioid use disorder. Journal Of Behavioral Addictions 2024 PMID: 39298267, DOI: 10.1556/2006.2024.00037.Peer-Reviewed Original ResearchAltmetricConceptsBrief Pornography ScreenOpioid use disorderPornography useOpioid use disorder treatmentUse disorderMeasures of substance useMeasures of impulsivityProblematic pornography useMinority of individualsNegative urgencyPositive urgencyPsychotic symptomsSelf-reported dataBehavioral addictionsGambling disorderPsychiatric disordersPsychiatric symptomsSensation-seekingEmotional labilitySelf-harmSubstance useDisordersOpioidIndividualsSymptomsDesign and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine
Machavariani E, Dumchev K, Pykalo I, Filippovych M, Ivasiy R, Esserman D, Madden L, Bromberg D, Haddad M, Morozova O, Ahmad B, Gómez D, Farnum S, Dvoriak S, Altice F. Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemporary Clinical Trials 2024, 146: 107690. PMID: 39265780, PMCID: PMC11531372, DOI: 10.1016/j.cct.2024.107690.Peer-Reviewed Original ResearchConceptsPrimary care centersQuality health indicatorsNon-communicable diseasesSpecialty treatment centersOpioid agonist therapyImplementation of integrated carePay-for-performance incentivesPrimary care clinicsPrimary care settingSelf-reported prevalencePay-for-performancePrevalence of medical comorbiditiesParticipants self-reportedEffective evidence-based treatmentsHealth of PWIDEvidence-based treatmentsIntegrated careCare clinicsImplementation outcomesImplementation trialCare settingsElectronic chart reviewHigh-burden countriesSpecialty servicesHIV prevalenceThe cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections
Ivasiy R, Madden L, DiDomizio E, Johnson K, Machavariani E, Ahmad B, Oliveros D, Ram A, Kil N, Altice F. The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections. Drug And Alcohol Dependence 2024, 263: 112410. PMID: 39159600, DOI: 10.1016/j.drugalcdep.2024.112410.Peer-Reviewed Original ResearchAltmetricConceptsOpioid use disorderXR-NTXUse disorderHCV infectionPrescribed MOUDOpioid use disorder cascadePrevalence of opioid use disorderRetrospective cohort studyHigher treatment retentionCascade of careConcurrent infectious diseasesSix-month retentionHCV/HIV coinfectionComorbid HIVCohort studyHospital-based settingPrescribed methadoneHCVMOUD initiationHIVHCV epidemicOpioidMethadoneMOUD prescriptionsTreatment retentionW96 Scaling up Opioid Agonist Therapies in Ukraine Before the War: Implementation Factors Related to Disruptions From Legislative Reform and COVID-19
Madden L, Ivasiy R, Polonsky M, Farnum S, Galvez S, Meteliuk A, Bromberg D, Altice F. W96 Scaling up Opioid Agonist Therapies in Ukraine Before the War: Implementation Factors Related to Disruptions From Legislative Reform and COVID-19. Drug And Alcohol Dependence 2024, 260: 110714. DOI: 10.1016/j.drugalcdep.2023.110714.Peer-Reviewed Original ResearchConceptsT107 Perceived Importance of Counseling Among Patients Receiving Methadone Treatment
Beitel M, Saeed G, Gazzola M, Eggert K, Roehrich T, Madden L, Barry D. T107 Perceived Importance of Counseling Among Patients Receiving Methadone Treatment. Drug And Alcohol Dependence 2024, 260: 110556. DOI: 10.1016/j.drugalcdep.2023.110556.Peer-Reviewed Original ResearchM135 Counselor Terminological Preferences for "Craving,” “Euphoria,” and “Withdrawal” Among Patients Receiving Methadone Treatment
Gazzola M, Beitel M, Buck K, Cammack K, Saeed G, Eggert K, Roehrich T, Madden L, Barry D. M135 Counselor Terminological Preferences for "Craving,” “Euphoria,” and “Withdrawal” Among Patients Receiving Methadone Treatment. Drug And Alcohol Dependence 2024, 260: 110415. DOI: 10.1016/j.drugalcdep.2023.110415.Peer-Reviewed Original ResearchS94 Patient Perspectives on an Open Access Model for Methadone Treatment: A Research and Process Improvement Protocol
Madden L, Farnum S, Eggert K, Cannata E, Hermes G, DiMeola K, Hoffman K, Barry D. S94 Patient Perspectives on an Open Access Model for Methadone Treatment: A Research and Process Improvement Protocol. Drug And Alcohol Dependence 2024, 260: 110205. DOI: 10.1016/j.drugalcdep.2023.110205.Peer-Reviewed Original ResearchS84 Lived Experiences of Addiction Counselors: A Protocol Exploring Stigma in a Time of Regulatory Change Within Opioid Treatment Programs
Eggert K, Madden L, Mabry B, Gjoni-Markaj E, Hoffman K, DiMeola K, Cannata E, Farnum S, Hermes G, Barry D. S84 Lived Experiences of Addiction Counselors: A Protocol Exploring Stigma in a Time of Regulatory Change Within Opioid Treatment Programs. Drug And Alcohol Dependence 2024, 260: 110195. DOI: 10.1016/j.drugalcdep.2023.110195.Peer-Reviewed Original Research
News
News
- October 27, 2023
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
- July 21, 2023
Ukrainian Refugees Face High Barriers to Opioid Use Disorder Treatment, Yale Study Finds
- November 16, 2022
Discoveries & Impact (November 2022)
- October 10, 2022
Patients Receiving Methadone Treatment Prefer Clinicians Use Medically Accurate and Destigmatizing Language